0.0180.00% ( 0.000 )
Delay Suspended: Nov 16, 12:59:29Valuation
Current ValuationThe current P/E ratio is -2.04, within the reasonable range, cheaper than 75.48% of the time in the past 1 years, and the industry ranks 16/22, the industry Median 6.34.
-2.04xP/E
HK$0.02Stock price
HK$-0.01Earnings per share
-2.04xP/E
Stock priceHK$0.02Earnings per shareHK$-0.01
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -2.04x
- Typical range
- -3.28x–-1.10x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.34x
05101520
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.34x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
02427HKGUANZE MEDICAL | -22.61x | -- | HK$1.87B |
02656HK160 HEALTH | -15.22x | -- | HK$906.30M |
01931HKETHK LABS INC. | -6.16x | -- | HK$529.42M |
00673HKCHINA HEALTH | -9.12x | -- | HK$436.95M |
02211HKUNI HEALTH | -17.15x | -- | HK$403.49M |
09955HKCLOUDR | -0.54x | 89.93% | HK$251.83M |
00718HKTAI UNITED HOLD | -0.39x | -- | HK$147.00M |
00401HKWANJIA GROUP | -12.36x | -- | HK$121.89M |
08156HKSINOPHARM TECH | -10.61x | -- | HK$96.96M |
02984HKNEW RAY MED-8K | -4.53x | -- | HK$73.23M |
00574HKPASHUN INT'L | -2.04x | -- | HK$35.83M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
